CIK 0001357459
- Non-accelerated filer
- Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522007292
- Phone
- +1 858-704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-21 | GRAY MARY ANN Director | Grant or award · Restricted Stock Units | +5,820 | 5,820 | ||
| 2023-11-21 | GRAY MARY ANN Director | Grant or award · Common Stock Options | +6,880 | 6,880 | ||
| 2023-06-11 | GRAY MARY ANN Director | Grant or award · Restricted Stock Units | +5,100 | 5,100 | ||
| 2023-06-11 | GRAY MARY ANN Director | Grant or award · Common Stock Options | +12,160 | 12,160 | ||
| 2021-11-18 | GRAY MARY ANN Director | Grant or award · Stock Option (right to buy) | +48,340 | 48,340 | ||
| 2021-04-01 | GRAY MARY ANN Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2020-04-03 | GRAY MARY ANN Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 |
Page 1 of 1 · 7 trades